Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial
- 31 August 1998
- Vol. 52 (2), 195-202
- https://doi.org/10.1016/s0090-4295(98)00184-8
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1998
- Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: Effects of finasterideUrology, 1997
- Serial Prostatic Biopsies in Men with Persistently Elevated Serum Prostate Specific Antigen ValuesJournal of Urology, 1994
- Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasiaUrology, 1994
- Effect of finasteride on prostate-specific antigen densityUrology, 1994
- Maintenance of Clinical Efficacy With Finasteride Therapy for 24 Months in Patients With Benign Prostatic HyperplasiaArchives of Internal Medicine, 1994
- The effect of finasteride on prostate‐specific antigen in men with benign prostatic hyperplasiaThe Prostate, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- Likelihood ratios with confidence: Sample size estimation for diagnostic test studiesJournal of Clinical Epidemiology, 1991
- The meaning and use of the area under a receiver operating characteristic (ROC) curve.Radiology, 1982